ESPR — ESPERION THERAPEUTICS INC NE

Ownership history in WOLVERINE TRADING, LLC  ·  48 quarters on record

This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in ESPERION THERAPEUTICS INC NE (ESPR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2018 Q1)
Avg. % of fund
0.0%
First filed
2016 Q2
Last filed
2025 Q3
Quarters held
48
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 16,100 -36,600 -69.4% 0.00% $43K $2.65
2025 Q3 ADDED 52,700 +41,895 +387.7% 0.00% $139K $2.65
2025 Q2 REDUCED 10,805 -14,395 -57.1% 0.00% $11K $0.98
2025 Q2 ADDED 25,200 +300 +1.2% 0.00% $25K $0.98
44 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ESPR price (monthly, adj. close)

Other funds also holding ESPR

As of 2025 Q4 — sorted by position size

AIGH Capital Management LLC 3Y 3.58% Velan Capital Investment Management LP 3Y 2.6% PenderFund Capital Management Ltd. 3Y 7Y 2.56% Two Seas Capital LP 3Y 0.91% Eversept Partners, LP 3Y 7Y 0.72% nVerses Capital, LLC 0.56% ORBIMED ADVISORS LLC 3Y 7Y 0.45% Summit Wealth Group, LLC 3Y 0.29% WASATCH ADVISORS LP 3Y 7Y 0.21% Virtus Investment Advisers, LLC 3Y 7Y 0.18%
← Back to WOLVERINE TRADING, LLC Holdings